Patents Assigned to VIVOZON, INC.
  • Publication number: 20240360092
    Abstract: Disclosed are a dual modulator of mGluR5 and 5-HT2AR (5-HT2A receptor), and use thereof. More specifically, disclosed are a compound which acts as modulator of mGluR5 and an antagonist of 5-HT2AR at the same time, and use thereof as therapeutic agent for pain.
    Type: Application
    Filed: July 1, 2024
    Publication date: October 31, 2024
    Applicant: Vivozon Inc.
    Inventors: Dae Kyu CHOI, Hyo Jin KIM, Mi Seon BAE, Jin CHOI, Hyun Jin HEO, Yong Seok LEE, Geon Ho LEE, Mi Yon SHIM, Jin Sun PARK, Han Mi LEE
  • Patent number: 12060339
    Abstract: Disclosed are a dual modulator of mGluR5 and 5-HT2AR (5-HT2A receptor), and use thereof. More specifically, disclosed are a compound which acts as modulator of mGluR5 and an antagonist of 5-HT2AR at the same time, and use thereof as therapeutic agent for pain.
    Type: Grant
    Filed: July 28, 2021
    Date of Patent: August 13, 2024
    Assignee: Vivozon Inc.
    Inventors: Dae Kyu Choi, Hyo Jin Kim, Mi Seon Bae, Jin Choi, Hyun Jin Heo, Yong Seok Lee, Geon Ho Lee, Mi Yon Shim, Jin Sun Park, Han Mi Lee
  • Publication number: 20220233492
    Abstract: A method for treating or preempting pain including postoperative pain following a soft or hard tissue surgery is disclosed. Also disclosed is a method for reducing an postoperative analgesic need, including administering a compound of Formula (I) or a salt thereof.
    Type: Application
    Filed: June 19, 2020
    Publication date: July 28, 2022
    Applicant: Vivozon Inc.
    Inventors: Doo Hyun LEE, Sunyoung CHO
  • Patent number: 9526718
    Abstract: Disclosed are a combination of active components inducing synergistic effects of multi-targeting and a use thereof. More particularly, disclosed are a functional food composition, a cosmetic composition, a pain-suppressive composition, and a composition for treatment or prevention of pruritus or atopic dermatitis, which comprise as active components, two or more components selected from a group consisting of (a) a 5-hydroxytryptamine subtype 2 (5-HT2) receptor antagonist; (b) a P2X receptor antagonist; and (c) any one of a glycine receptor agonist, a glycine transporter (GlyT) antagonist, a gamma-aminobutyric acid (GABA) receptor agonist, and a GABA transporter 1 (GAT1) antagonist.
    Type: Grant
    Filed: June 28, 2012
    Date of Patent: December 27, 2016
    Assignee: VIVOZON, INC.
    Inventors: Doo Hyun Lee, Sunyoung Cho
  • Patent number: 9359346
    Abstract: Disclosed are a novel benzamide derivative and pharmaceutical use thereof, and more particularly, a novel benzamide derivative having a structure of Formula 1 or pharmaceutically acceptable salts thereof, and a composition for prevention or treatment of pain or itching including the above material. The novel benzamide derivative and pharmaceutically acceptable salt thereof according to the present invention exhibit excellent pain-suppressive effect and, in particular, pain-suppressive effect in not only a neuropathic animal model but also other models such as a formalin model, and therefore, may be used in suppression of different pains such as nociceptive pain, chronic pain, etc.
    Type: Grant
    Filed: November 29, 2012
    Date of Patent: June 7, 2016
    Assignee: VIVOZON, INC.
    Inventors: Doo Hyun Lee, Myung Soo Ham, Ji-Hyun Lee